Sox9-IRES-CreERT2
Nomenclature
C57BL/6Smoc-Sox9em(IRES-CreERT2-SV40pA)Smoc
Cat. NO.
NM-KI-204996
Strain State
Sperm cryopreservation
Gene Summary
Gene Symbol
Sox9
Model Description
Validation Data

Fig. 1 CreERT2-mediated recombination in the heart of Sox9CreERT2/+;R26tdtomato/+ mouse. TdTomato can be detected in the heart of Sox9CreERT2/+;R26tdtomato/+ mouse. (Documented in the following reference.)

Fig. 2 CreERT2-mediated recombination in the heart of Sox9CreERT2 /+; Rosa26tdTomato/+ mouse. TdTomato(red) expression can be detected in some cells of ventricle and atria derived from Sox9CreERT2 /+; Rosa26tdTomato/+ mouse after tamoxifen treatment.

Fig. 3 CreERT2-mediated recombination in the hair follicles of Sox9CreERT2 /+; Rosa26tdTomato/+ mouse. TdTomato(red) expression can be detected in the hair follicles and epidermis derived from Sox9CreERT2 /+; Rosa26tdTomato/+ mouse.

Fig. 4 CreERT2-mediated recombination in the liver of Sox9CreERT2 /+; Rosa26tdTomato/+ mouse. TdTomato(red) expression can be detected in the liver of Sox9CreERT2 /+; Rosa26tdTomato/+ mouse.

Fig. 5 Detection of tdTomato(red) in various tissues of Sox9CreERT2/+; Rosa26tdTomato/+ mice. CreERT2 mediated recombination can be detected in the heart, hair follicles and epidermis. Tdtomato expression can be also detected in individual cells derived from liver, brain, pituitary gland, retina, stomach, large intestine, small intestine, lung, submandibular gland, kidney, pancreas, spleen, thymus and ovary, except for brown fat tissue and muscle. (For more detailed information please contact our technical advisor.)
Publications 1piece
You may also like
On Dec 16, 2018, Broad Institute and Shanghai Model Organisms Center Inc (SMOC) has entered into a non-exclusive license agreement under which Broad has granted SMOC worldwide rights to commercialize a service platform for genetically modified mouse models under Broad's intellectual property.
Learn moreSMOC’s Annual Progress and Advances in Preclinical immuno-Oncology Research: The workshop is designed as a forum for ideas and opinions exchange on how to decrease the rate of clinical failures in oncology and immuno-oncology.
Learn more